Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI841649Aexternal-prioritypatent/FI81365C/en
Application filed by George Joseph TodarofiledCriticalGeorge Joseph Todaro
Publication of FI883765A0publicationCriticalpatent/FI883765A0/en
Publication of FI883765ApublicationCriticalpatent/FI883765A/en
Priority to FI900177ApriorityCriticalpatent/FI89061C/en
Application grantedgrantedCritical
Publication of FI81497BpublicationCriticalpatent/FI81497B/en
Publication of FI81497CpublicationCriticalpatent/FI81497C/en
The invention relates to antibodies which are formed by new biologically active polypeptides, inclusive of a new class of transformation growth factor - TGF - polypeptides which exhibit cell growth-promoting properties, and by antigenic oligopeptides derived from the TGF polypeptides. These antibodies are of use in diagnostics and the invention also relates to the detection of cancer and other proliferative diseases and brittle bone disease with the aid of these antibodies.
FI883765A1983-05-091988-08-12
ANTIKROPPAR MOT BIOLOGISKT AKTIVA POLYPEPTIDER OCH DERAS ANVAENDNING VID DIAGNOSTISKA FOERFARANDEN.
FI81497C
(en)
HUMAN GAMMA INTERFERON-SPECIFIC RECEPTOR PROTEIN, ANTIBODIES AGAINST THIS PROTEIN, METHOD FOR THE PRODUCTION OF THIS PROTEIN AND THIS ANTIBODY AND THIS PROTEIN AND THIS ANTIBODY CONTAINING.